Genetic variations in human G protein-coupled receptors: Implications for drug therapy
- 1 September 2001
- journal article
- review article
- Published by Springer Nature in AAPS PharmSci
- Vol. 3 (3) , 54-80
Abstract
No abstract availableKeywords
This publication has 143 references indexed in Scilit:
- Initial sequencing and analysis of the human genomeNature, 2001
- A Genetic Polymorphism in the Promoter Region of DRD4 Associated with Expression and SchizophreniaBiochemical and Biophysical Research Communications, 1999
- β2-adrenoceptor gene polymorphism, body weight, and physical activityThe Lancet, 1999
- Increased prevalence of the Taq I A1allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary reportPharmacogenetics, 1996
- Minireview: Mutations and Diseases of G Protein Coupled ReceptorsJournal of Receptors and Signal Transduction, 1995
- Binding of 5H-Dibenzo[b,e][1,4]diazepine and Chiral 5H-Dibenzo[a,d]cycloheptene Analogs of Clozapine to Dopamine and Serotonin ReceptorsJournal of Medicinal Chemistry, 1994
- Expanding horizons for receptors coupled to G proteins: diversity and diseaseCurrent Opinion in Cell Biology, 1994
- Rhodopsin mutation G90D and a molecular mechanism for congenital night blindnessNature, 1994
- Accelerated communciation: Constitutive μ opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependenceLife Sciences, 1994
- Functional Characterization of the Cloned Human ACTH Receptor: Impaired Responsiveness of a Mutant Receptor in Familial Glucocorticoid DeficiencyBiochemical and Biophysical Research Communications, 1993